Trump’s ‘America First’ Vaccine Agenda May Leave Us Last

By using the usual patent monopoly framework rather than international open-source collaboration, the coronavirus vaccine may prove both elusive and more costly for Americans.

by

Fortify your mind! Join the Prospect today

Support The American Prospect's independent, nonprofit journalism by becoming a member today. You will stay engaged with the best and brightest political and public policy reporting and analyses, and help keep this website free from paywalls and open for all to read. Our membership levels offer a range of perks including an opt-in to receive the print magazine by mail.